Latest liver disease Stories
TEL AVIV, Israel, Feb. 25, 2015 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
DALLAS, February 1, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Non Alcoholic Fatty Liver Disease (NAFLD) Global Pipeline and Clinical Trials Review, H1, 2015 research
RnRMarketResearch.com adds “Primary Sclerosing Cholangitis – Pipeline Review, H1 2015” to its store.
TEL AVIV, Israel, Jan. 6, 2015 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
Dignity Sciences today announced positive results with its anti-fibrotic compound DS102 in preclinical studies which assessed its potential effectiveness for the treatment of non-alcoholic steatohepatitis
PERTH, Australia, Nov.
TEL AVIV, Israel, Nov. 5, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
SOUTH SAN FRANCISCO, Calif., Oct.
Researchers at the University of Missouri School of Medicine have identified epigenetic protein changes caused by binge drinking, a discovery that could lead to treatments for alcohol-related liver diseases.
CF102 has shown to induce healthy liver cell proliferation resulting in improved liver status PETACH TIKVA, Israel, Sept.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.